Genocea: Genocea Biosciences to shut down

Genocea Biosciences Inc. on Tuesday told investors it plans to shut down and lay off all remaining employees. The company said it gave notice to The Nasdaq Stock Market Inc. for its plans to voluntarily delist its common stock and said it plans to file a Form 25 with the Securities and Exchange Commission by June 2. Genocea was developing immunotherapies for people with cancer. The company's stock had tumbled 94.7% this year, while the broader S&P 500 is down 17.3%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.